[HTML][HTML] Cost–effectiveness of apixaban and warfarin in the prevention of thromboembolic complications among atrial fibrillation patients

T Hallinen, EJ Soini, M Linna, SI Saarni - Springerplus, 2016 - Springer
Background To reduce the risk of thromboembolic complications, clinical guidelines
recommend anticoagulation treatment for almost all atrial fibrillation (AF) patients. Although …

[PDF][PDF] Cost–effectiveness of apixaban and warfarin in the prevention of thromboembolic complications among atrial fibrillation patients

T Hallinen, EJ Soini, M Linna, SI Saarni - 2016 - acris.aalto.fi
Background: To reduce the risk of thromboembolic complications, clinical guidelines
recommend anticoagulation treatment for almost all atrial fibrillation (AF) patients. Although …

Cost-effectiveness of apixaban and warfarin in the prevention of thromboembolic complications among atrial fibrillation patients

T Hallinen, EJ Soini, M Linna, SI Saarni - SpringerPlus, 2016 - pubmed.ncbi.nlm.nih.gov
Background To reduce the risk of thromboembolic complications, clinical guidelines
recommend anticoagulation treatment for almost all atrial fibrillation (AF) patients. Although …

Cost-effectiveness of apixaban and warfarin in the prevention of thromboembolic complications among atrial fibrillation patients

T Hallinen, EJ Soini, M Linna, SI Saarni - 2016 - aaltodoc.aalto.fi
Background: To reduce the risk of thromboembolic complications, clinical guidelines
recommend anticoagulation treatment for almost all atrial fibrillation (AF) patients. Although …

Cost–effectiveness of apixaban and warfarin in the prevention of thromboembolic complications among atrial fibrillation patients

T Hallinen, EJ Soini, M Linna, SI Saarni - SpringerPlus, 2016 - infona.pl
Background To reduce the risk of thromboembolic complications, clinical guidelines
recommend anticoagulation treatment for almost all atrial fibrillation (AF) patients. Although …

Cost-effectiveness of apixaban and warfarin in the prevention of thromboembolic complications among atrial fibrillation patients

T Hallinen, EJ Soini, M Linna, SI Saarni - SpringerPlus, 2016 - search.proquest.com
Background To reduce the risk of thromboembolic complications, clinical guidelines
recommend anticoagulation treatment for almost all atrial fibrillation (AF) patients. Although …

Cost-effectiveness of apixaban and warfarin in the prevention of thromboembolic complications among atrial fibrillation patients

T Hallinen, EJ Soini, M Linna, SI Saarni - SPRINGERPLUS, 2016 - research.aalto.fi
Background: To reduce the risk of thromboembolic complications, clinical guidelines
recommend anticoagulation treatment for almost all atrial fibrillation (AF) patients. Although …

Cost-effectiveness of apixaban and warfarin in the prevention of thromboembolic complications among atrial fibrillation patients.

T Hallinen, EJ Soini, M Linna, SI Saarni - Springerplus, 2016 - europepmc.org
Background To reduce the risk of thromboembolic complications, clinical guidelines
recommend anticoagulation treatment for almost all atrial fibrillation (AF) patients. Although …

[HTML][HTML] Cost–effectiveness of apixaban and warfarin in the prevention of thromboembolic complications among atrial fibrillation patients

T Hallinen, EJ Soini, M Linna… - …, 2016 - springerplus.springeropen.com
To reduce the risk of thromboembolic complications, clinical guidelines recommend
anticoagulation treatment for almost all atrial fibrillation (AF) patients. Although warfarin has …

[PDF][PDF] Cost–effectiveness of apixaban and warfarin in the prevention of thromboembolic complications among atrial fibrillation patients

T Hallinen, EJ Soini, M Linna, SI Saarni - 2016 - utupub.fi
Background: To reduce the risk of thromboembolic complications, clinical guidelines
recommend anticoagulation treatment for almost all atrial fibrillation (AF) patients. Although …